Does my employer health plan cover GLP-1s?

TLDR. Your employer health plan may or may not cover GLP-1 medications like Wegovy or Zepbound, and the answer has almost nothing to do with your insurer. It depends on decisions your employer made when designing the plan. Fully-insured plans follow the insurer’s standard formulary; self-insured (ERISA) plans follow whatever benefit design your employer chose. Here is how to find out where you stand, and what questions actually get you a useful answer.

Why your employer decides, not your insurer

Most people assume their insurance company decides what’s covered. For the 160 million Americans with employer-sponsored insurance, that is only half true.

There are two fundamentally different plan structures. In a fully-insured plan, your employer pays premiums to a commercial insurer (Aetna, United, BCBS) and the insurer assumes the risk and sets the formulary. If Aetna’s standard formulary covers Wegovy, fully-insured Aetna members get that coverage, regardless of which employer sponsors the plan.

In a self-insured (or self-funded) plan, your employer pays the actual claims out of its own funds. It hires a commercial insurer or third-party administrator to process claims, but the benefit design is the employer’s choice. If your employer decided GLP-1s for obesity were too expensive and excluded them, they are excluded, even if the same insurer’s fully-insured plans cover them. Your Aetna ID card looks identical. The underlying plan design is completely different.

About two-thirds of covered workers are in self-insured plans, according to the Department of Labor’s Medical Expenditure Panel Survey. That share rises to over 80 percent at employers with 1,000 or more workers.

How to find out which type of plan you have

You do not have to guess. Three documents tell you.

Summary Plan Description (SPD). Every employer-sponsored plan must provide an SPD under ERISA. It describes benefits, exclusions, and the governing law. Look for the phrase “self-insured,” “self-funded,” or “stop-loss insurance.” Those words mean your employer is bearing the claims risk. If the SPD says nothing about self-insurance and mentions the insurer’s standard benefit schedule, it is likely fully-insured.

Summary of Benefits and Coverage (SBC). The SBC is a standardized two-page document (required by the ACA) that outlines what the plan covers. It will not always tell you about self-insurance, but it tells you whether GLP-1 drugs appear as a covered benefit or in the exclusions list.

Formulary drug list. Your plan’s formulary lists every covered drug by tier. Search for “semaglutide,” “tirzepatide,” “Wegovy,” and “Zepbound.” If any appear, and are not in an exclusions note, the plan covers them, subject to prior authorization criteria.

You can request all three documents from your HR or benefits department. ERISA requires the employer to provide the SPD within 30 days of a written request.

What to ask HR

Generic “do you cover weight loss drugs” questions get generic answers. These specific questions get useful ones.

• “Is our health plan self-insured or fully-insured?” This is the most important question and HR should be able to answer it directly.
• “Do semaglutide or tirzepatide appear on the plan formulary?” Use the drug names, not the brand names. Formulary decisions sometimes cover one molecule and not the other.
• “Does the plan cover GLP-1 medications for obesity, or only for diabetes?” Many plans cover Ozempic or Mounjaro for type 2 diabetes but exclude Wegovy or Zepbound for weight management. The molecules are the same. The coverage rules are different.
• “Is there an annual benefit maximum or lifetime cap on these medications?” Some plans that technically cover GLP-1s cap the annual benefit at $2,000 or $3,000, which covers only two or three months at list price.
• “Is a prior authorization required?” Almost always yes, but ask so you can prepare the documentation in advance. See the prior authorization step-by-step guide.

Why coverage has grown but unevenly

The KFF 2024 Employer Health Benefits Survey found that 26 percent of large employers (500 or more workers) covered GLP-1s for obesity in 2024, up from 4 percent in 2022. The cost pressure explains both the growth and the ceiling. Annual GLP-1 claims per covered member run $10,000 to $15,000. For a mid-size employer self-insuring a 2,000-person workforce, adding GLP-1 obesity coverage means a potential seven-figure annual exposure in year one before any clinical offsets.

That math lands very differently at different employers. A tech firm with high average salary and low cost-sensitivity adds coverage to compete for talent. A distribution company with thin margins and high turnover excludes it to protect the benefit budget. Both decisions are legal. Both reflect real economic constraints.

If your plan does not cover GLP-1s for obesity

You have options, though none are as cheap as covered drugs at a $50 copay.

The lowest cash-pay floor today: compounded semaglutide from about $178/mo through programs like Mochi, or Zepbound vials from $299/mo via LillyDirect, or the Medicare GLP-1 Bridge at $50/mo from July 1, 2026 for qualifying Medicare patients. For those without coverage and without Medicare, the GLP-1 cost guide maps every current cash-pay path.

If your plan covers GLP-1s for type 2 diabetes but not obesity, and you have a diabetes diagnosis, that coverage applies. Your prescriber documents the indication on the prior authorization.

If your employer is self-insured, you also have an avenue most patients miss: asking the employer directly to add GLP-1 coverage or grant a formulary exception. That process is covered in how to get your employer to add GLP-1 coverage.

If your plan covers GLP-1s and you’ve been denied, the ERISA appeals guide walks through the internal and external appeal sequence.

Frequently asked questions

Does my employer have to cover GLP-1s for obesity?

No. Federal law does not require employer health plans to cover GLP-1 medications for obesity. The decision is made by the employer for self-insured plans, and by the insurer for fully-insured plans. Coverage has grown but is still a minority of plans. Source: KFF 2024 Employer Health Benefits Survey.

What is the difference between a fully-insured and self-insured health plan?

In a fully-insured plan, your employer pays premiums to an insurer who sets the benefit design and bears the claims risk. In a self-insured plan, your employer pays the actual claims and decides which benefits are covered; an insurer or third-party administrator processes claims on the employer’s behalf. Most large employers are self-insured. Source: US Department of Labor.

My Aetna or BCBS card says covered, but the pharmacy says GLP-1s are excluded. What happened?

You are probably on a self-insured plan administered by Aetna or BCBS. The insurer’s own fully-insured formulary may cover GLP-1s; your employer’s self-insured plan may have excluded them. Ask HR whether the plan is self-insured and request the Summary Plan Description to see the exclusions list.

Can I use HSA or FSA funds to pay for GLP-1s without coverage?

Yes, when prescribed for a covered medical condition. HSA and FSA dollars can be used for prescription medications, reducing effective cost by your marginal tax rate (typically 22 to 32 percent). See the HSA/FSA guide for specifics on eligible expenses and documentation.